quizartinib,Cytarabine,Idarubicin
daiichi sankyo
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
congress | #eha2023 pau montesinos, presents preliminary results from the phase ii quiwi trial. results indicate that the addition of quizartinib to 3+7 may improve survival vs placebo in patients with newly diagnosed flt3-itd wt aml. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm